Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.007.24%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -233.41% | -71.82% | -19.08% | 28.06% | 57.28% |
| Total Depreciation and Amortization | 38.87% | 5.79% | 286.33% | -131.31% | 6.99% |
| Total Amortization of Deferred Charges | 795.34% | -- | -- | -93.34% | -93.59% |
| Total Other Non-Cash Items | 59,471.43% | -41.67% | 233.33% | -175.00% | 71.43% |
| Change in Net Operating Assets | 428.10% | -22.23% | -26.65% | 3.77% | -4.55% |
| Cash from Operations | 65.94% | -1,147.46% | -84.95% | 39.03% | 201.88% |
| Capital Expenditure | -103.25% | -- | -- | 6.72% | -1.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -103.25% | -- | -- | 6.72% | -1.71% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -209.53% | 585.29% | -82.67% | 50.21% | 481.70% |